CBT-I to Improve Functional Outcomes in Veterans With Psychosis

Last updated: February 17, 2026
Sponsor: VA Office of Research and Development
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Insomnia

Schizophrenia And Schizoaffective Disorders (Pediatric)

Psychosis

Treatment

Cognitive Behavioral Therapy-Insomnia

Health and Wellness

Clinical Study ID

NCT04646200
D3213-R
I01RX003213
  • Ages 18-80
  • All Genders

Study Summary

The goal of this project is to examine the efficacy of Cognitive Behavioral Therapy for Insomnia (CBT-I) for improving sleep and related functional outcomes in Veterans with psychosis and insomnia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • meet criteria for SMI: Schizophrenic disorder, affective psychosis, major depressionwith psychotic features, delusional disorder, brief psychotic disorder, unspecifiedpsychotic disorder, schizotypal personality disorder

  • be between the ages of 18 and 80

  • be actively participating in outpatient mental health services at designated site

Exclusion

Exclusion Criteria:

  • currently in CBT-I treatment

  • planning to move out of the area during the study period

Study Design

Total Participants: 152
Treatment Group(s): 2
Primary Treatment: Cognitive Behavioral Therapy-Insomnia
Phase:
Study Start date:
November 29, 2021
Estimated Completion Date:
November 30, 2026

Study Description

The goal of this project is to examine the efficacy of Cognitive Behavioral Therapy for Insomnia (CBT-I) for improving sleep and related functional outcomes in Veterans with psychosis and insomnia.

Aim 1: Evaluate the efficacy of CBT-I for reducing insomnia severity in Veterans with psychosis and insomnia.

Hypothesis 1: CBT-I participants, as compared to those in an active control condition, will show significantly greater reductions on the Insomnia Severity Index at post-treatment and at a 6-month follow-up.

Aim 2: Evaluate the efficacy of CBT-I for improving the functioning of Veterans with psychosis and insomnia. Hypothesis 2: CBT-I participants, as compared to those in an active control condition, will show significantly greater increases in mental and physical health functioning on the Veterans RAND 36-Item Health Survey at post-treatment and at a 6-month follow-up.

Aim 3: Evaluate the process that underlies the relationship between insomnia severity and functioning in Veterans with psychosis and insomnia.

Hypothesis 3: The effect of CBT-I on mental and physical health functioning at post-treatment will be mediated by reductions in insomnia severity at week 5 of treatment.

Hypothesis 4: The effect of CBT-I on mental and physical health functioning at the 6-month follow-up will be mediated by reductions in insomnia severity at immediate post-treatment.

Exploratory Aim: Explore whether psychiatric symptoms 1) moderate the impact of CBT-I on insomnia and functioning and/or 2) change as a result of participation in CBT-I.

Connect with a study center

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    Baltimore, Maryland 21201
    United States

    Site Not Available

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

    Baltimore 4347778, Maryland 4361885 21201
    United States

    Site Not Available

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Philadelphia, Pennsylvania 19104
    United States

    Site Not Available

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Philadelphia 4560349, Pennsylvania 6254927 19104
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.